Provider

Caring for OutPatiEnts after Acute Kidney Injury Trial

This is a kidney research study to find out if an enhanced care team approach can improve outcomes after hospitalization with acute kidney injury (AKI). Participants who enroll in the study will be randomized to two arms of the study – an arm that receives a team approach (referred to as team intervention) or care that is current and typical for AKI care (referred to as usual care).

All participants in the study will be asked to complete questionnaires, medical history, blood pressure, and blood and urine tests. These assessments will be done prior to discharge from the hospital, and at 30 days, 90 days, 6 months, and one year.

Participants assigned to the usual care and team intervention will receive information about AKI and recommendations to follow up with their providers. Additionally, participants in the team intervention will receive care recommendations from a study team that includes a nurse navigator, pharmacist, and nephrologist, plus home blood pressure and weight monitoring. The nurse navigator will be the participant’s primary contact and will work to enhance communication between the team and the participant’s providers. There will be regular visits, either by telehealth (video or telephone) or in person with the nurse navigator and pharmacist, in addition to the other study visits.

As a provider, what do I get from having a patient enrolled in the COPE-AKI study?

Individuals may be eligible to participate in this research study if they currently had acute kidney injury (AKI) during their time in the hospital.

Video ara pacientes en español

Would you like to learn more?

To learn more about Caring for OutPatiEnt After Kidney Injury download the Provider Summary or Patient Summary flyer.  

Study details can be found on the Clinical Trials. gov website by clicking here.   Find out more about privately and publicly funded clinical studies conducted around the world at ClinicalTrials.gov.

Interested in finding out more, contact us. 

Cleveland Clinic AKI study